ProKidney (PROK) Insider Trading & Ownership $2.49 0.00 (-0.08%) As of 11:29 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProKidney (NASDAQ:PROK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage41.49%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.18MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$353.54K Get PROK Insider Trade Alerts Want to know when executives and insiders are buying or selling ProKidney stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PROK Insider Buying and Selling by Quarter ProKidney Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/8/2025Darin J. WeberInsiderSell103,480$3.02$312,509.60 4/22/2025Control Empresarial De CapitalInsiderBuy387,393$0.71$275,049.03 4/16/2025Control Empresarial De CapitalInsiderBuy100,000$0.75$75,000.00 4/14/2025Control Empresarial De CapitalInsiderBuy268,105$0.73$195,716.65 4/10/2025Control Empresarial De CapitalInsiderBuy1,032,218$0.61$629,652.98 9/19/2024Darin J WeberInsiderSell16,412$2.50$41,030.00 (Data available from 1/1/2013 forward) PROK Insider Trading Activity - Frequently Asked Questions Who is on ProKidney's Insider Roster? The list of insiders at ProKidney includes Chamath Palihapitiya, Control Empresarial De Capital, Darin J Weber, and Pablo G Legorreta. Learn more on insiders at PROK. What percentage of ProKidney stock is owned by insiders? 41.49% of ProKidney stock is owned by insiders. Learn more on PROK's insider holdings. Which ProKidney insiders have been buying company stock? The following insiders have purchased PROK shares in the last 24 months: Control Empresarial De Capital ($21,359,116.70), and Pablo G Legorreta ($54,735,339.78). How much insider buying is happening at ProKidney? Insiders have purchased a total of 32,797,087 PROK shares in the last 24 months for a total of $76,094,456.48 bought. Which ProKidney insiders have been selling company stock? The following insiders have sold PROK shares in the last 24 months: Chamath Palihapitiya ($23,379,021.49), and Darin J Weber ($345,817.61). How much insider selling is happening at ProKidney? Insiders have sold a total of 11,533,142 ProKidney shares in the last 24 months for a total of $24,037,348.70 sold. ProKidney Key ExecutivesDr. Bruce Culleton M.D. (Age 56)CEO & Director Compensation: $657.93kDr. Timothy A. Bertram D.V.M. (Age 69)Ph.D., Founder Compensation: $1.46MMr. James Coulston CPA (Age 47)Chief Financial Officer Compensation: $533.15kMr. Todd C. Girolamo Esq. (Age 59)J.D., M.B.A., Chief Legal Officer & Secretary Compensation: $541.59kMs. Mary Weger (Age 65)Chief People Officer Dr. Joseph M. Stavas M.D.M.P.H., Senior VP of Interventional Procedures & Patient SafetyDr. Darin J. Weber Ph.D. (Age 56)Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access Mr. Nikhil L. Pereira-KamathChief Business OfficerMr. Richard WilliamsSenior Vice President of Information TechnologyDr. Aparna Sahoo M.D.VP & Head of Global Clinical Development More Insider Trading Tools from MarketBeat Related Companies IMVT Insider Selling GMTX Insider Selling CPRX Insider Selling KNSA Insider Selling OGN Insider Selling TARS Insider Selling CNTA Insider Selling AGIO Insider Selling IBRX Insider Selling IDYA Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Reynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big Upside This page (NASDAQ:PROK) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProKidney Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProKidney With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access